American Heart Journal

Article	Citations
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design	161
Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure	97
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance	89
Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial	89
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study	88
Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes—Systematic review and meta-analysis of randomized placebo-controlled trials	80
Shock in the cardiac intensive care unit: Changes in epidemiology and prognosis over time	78
Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care	73
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study	69
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficac	65
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	63
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial	60
Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial	57
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and	56
Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19	54
To Adjust or Not to Adjust: The Role of Different Covariates in Cardiovascular Observational Studies	50
Trends of blood pressure control in the U.S. during the COVID-19 pandemic	49
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)	49
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study	46
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline chara	45
Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial	45
Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update	44
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study	42
Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy	40
Diagnosis, prevention, and management of delirium in the intensive cardiac care unit	39

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study	36
Financial burden, distress, and toxicity in cardiovascular disease	35
Reducing disparities in adverse pregnancy outcomes in the United States	35
Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices	34
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE	34
Periodontal Disease, Atrial Fibrillation and Stroke	32
Association of gut-related metabolites with outcome in acute heart failure	31
Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic	30
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	29
Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial	29
Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) - The CAPLA study	28
Rationale and methods of the Advanced R2Eperfusion STrategies for Refractory Cardiac Arrest (ARREST) trial	28
Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018	28
Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study	27
Association between ambient air pollution and county-level cardiovascular mortality in the United States by social deprivation index	27
Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial)	26
Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial	25
Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction–related cardiogenic shock from 2005 to 2017: A nationwide cohort study	25
Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes	25
Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity	25
Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival	24
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optic	23
Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: Rationale and design of the PEERLESS study	23
A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design	22
Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial	22
Coarctation of aorta is associated with left ventricular stiffness, left atrial dysfunction and pulmonary hypertension	22
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting sten	22
Adherence with lipid screening guidelines in standard- and high-risk children and adolescents	22
The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic he	21
Batch enrollment for an artificial intelligence-guided intervention to lower neurologic events in patients with undiagnosed atrial fibrillation: rationale and design of a digital clinical trial	21
Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and prese	20
The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives	20
Sex disparities in patients with symptomatic severe aortic stenosis	20
The trial to assess chelation therapy 2 (TACT2): Rationale and design	20
Sacubitril/valsartan versus enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study	19
Atrial fibrillation detection using ambulatory smartwatch photoplethysmography and validation with simultaneous holter recording	19
Neighborhood education status drives racial disparities in clinical outcomes in PPCM	19
Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: Rationale and design of the randomized Altshock-2 trial	19
Internet search volume for chest pain during the COVID-19 pandemic	18
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic	18
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study	18
Sociodemographic differences in utilization and outcomes for temporary cardiovascular mechanical support in the setting of cardiogenic shock	18
Noninvasive echocardiographic cardiac power output predicts mortality in cardiac intensive care unit patients	18
Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial	17
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy	17
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) – A phase III study	17
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale	17
Move more – be happier? physical activity and health-related quality of life in children with congenital heart disease	17
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5	16
Trends in transcatheter and surgical aortic valve replacement in the United States, 2008-2018	16

Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTl	16
Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis	16
Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: Rationale, design, and baseline findings of the FAITH! Trial	16
Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction	16
Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol	16
Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)	16
Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial	16
Cardiac resynchronization therapy improves the ventricular function of patients with Fontan physiology	16
Cardiac safety research consortium “shock II” think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock	15
Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial	15
Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: A nationwide study	15
Randomized evaluation of vessel preparation with orbital atherectomy prior to drug-eluting stent implantation in severely calcified coronary artery lesions: Design and rationale of the ECLIPSE trial	15
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction	15
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study	15
Early rehabilitation in older patients hospitalized with acute decompensated heart failure: A retrospective cohort study	15
The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial	15
One-year outcome after percutaneous coronary intervention in nonagenarians: Insights from the J-PCI OUTCOME registry	14
iPhone App compared with standard blood pressure measurement –The iPARR trial	14
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic	14
Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with ora	14
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction	14
Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial	14
International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design	14
Patient-centered contrast thresholds to reduce acute kidney injury in high-risk patients undergoing percutaneous coronary intervention	14
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	14
Text messages for primary prevention of cardiovascular disease: The TextMe2 randomized clinical trial	14
Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	14
Nationwide cardiovascular disease admission rates during a second COVID-19 lockdown	14
Cardiovascular procedural deferral and outcomes over COVID-19 pandemic phases: A multi-center study	14
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial	14
Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis	14
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	13
Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial	13
Individuals aged 1-64 years with documented congenital heart defects at healthcare encounters, five U.S. surveillance sites, 2011-2013	13
A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19	13
Incidence of acute coronary syndrome during national lock-down: Insights from nationwide data during the Coronavirus disease 2019 (COVID-19) pandemic	13
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomiz	13
Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers a	13
Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials	13
Distal versus conventional radial access for coronary angiography and intervention: Design and rationale of DISCO RADIAL study	13
The impact of left atrium size on selection of the pulmonary vein isolation method for atrial fibrillation: Cryoballoon or radiofrequency catheter ablation	13
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction	13
Rationale and Design of the Groningen Intervention Study for the Preservation of Cardiac Function with Sodium Thiosulfate after St-segment Elevation Myocardial Infarction (GIPS-IV) trial	13
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations	13
Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial	13
Menopausal age and left ventricular remodeling by cardiac magnetic resonance imaging among 14,550 women	13
Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study	13
Transcatheter mitral valve repair for inotrope dependent cardiogenic shock – Design and rationale of the CAPITAL MINOS trial	13
High-Sensitivity Cardiac Troponin—Optimizing the Diagnosis of Acute Myocardial Infarction/Injury in Women (CODE-MI): Rationale and design for a multicenter, stepped-wedge, cluster-randomized trial	12
Potent P2Y12 inhibitors versus Clopidogrel in elderly patients with acute coronary syndrome: Systematic review and meta-analysis	12
Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial	12
Harmonization of the definition of sudden cardiac death in longitudinal cohorts of the European Sudden Cardiac Arrest network – towards Prevention, Education, and New Effective Treatments (ESCAPE-NET)	12
Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial	12
Whole genome sequencing in transposition of the great arteries and associations with clinically relevant heart, brain and laterality genes	12
Cardiac transplantation outcomes in patients with amyloid cardiomyopathy	12
The association of healthcare disparities and patient-specific factors on clinical outcomes in peripheral artery disease	12
Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	12
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial	12
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, rando	12
Short-term PM2.5 exposure and early-readmission risk: a retrospective cohort study in North Carolina heart failure patients	11
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)	11
Epidemiologic trends and risk factors associated with the decline in mortality from coronary heart disease in the United States, 1990-2019	11
Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary	11
Cardiogenic shock complicating non-ST-segment elevation myocardial infarction: An 18-year study	11
Virtual AppLication-supported Environment To INcrease Exercise (VALENTINE) during cardiac rehabilitation study: Rationale and design	11
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19)	11
Modified design of stimulation of the left ventricular endocardium for cardiac resynchronization therapy in nonresponders, previously untreatable and high-risk upgrade patients (SOLVE-CRT) trial	11
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study	11
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups	11
Overview of the FDA's Circulatory System Devices Panel virtual meeting on the TransMedics Organ Care System (OCS) Heart – portable extracorporeal heart perfusion and monitoring system	11
Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms	11
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry	11
Defect-free care trends in the Paul Coverdell National Acute Stroke Program, 2008-2018	11
Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data	11
Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE)	11
Is the affordable care act medicaid expansion associated with receipt of heart failure guideline-directed medical therapy by race and ethnicity?	11
Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease	11
Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneo	10
Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs	10

Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy	10
Rationale and design of the comparison of outcomes and access to care for heart failure (COACH) trial: A stepped wedge cluster randomized trial	10
Long-term incidence of infective endocarditis among patients with congenital heart disease	10
Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study	10
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	10
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	10
Interventional cardiologists’ perceptions of percutaneous coronary intervention quality measurement and feedback	10
CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)	10
Rationale and design of switch Swedeheart: A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute co	10
National trends and 30-day readmission rates for next-day-discharge transcatheter aortic valve replacement: An analysis from the Nationwide Readmissions Database, 2012-2016	10
Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review	10
Female sex-specific and -predominant cardiovascular risk factors and heart failure practice guidelines	10
Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: A prospective study	10
Safety and efficacy of exercise training in children and adolescents with congenital heart disease: A systematic review and descriptive analysis	10
Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk	10
Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease	10
Prevalence of ideal cardiovascular health in young adults: A birth cohort from southern Brazil	10
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial	10
Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARI	10
A randomized controlled trial of gamification, financial incentives, or both to increase physical activity among patients with elevated risk for cardiovascular disease: rationale and design of the be	10
Coronary angiography-derived index for assessing microcirculatory resistance in patients with non-obstructed vessels: The FLASH IMR study	10
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	10
Long-term outcomes of arrhythmia and distinct electrophysiological features in congenitally corrected transposition of the great arteries in an Asian cohort	10
Sex and race differences in safety and effectiveness of the HEART pathway accelerated diagnostic protocol for acute chest pain	9
Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: Findings from ASCEND-HF	9
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model	9
Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial	9
Delayed medical care due to transportation barriers among adults with atherosclerotic cardiovascular disease	9
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	9
Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation	9
In-hospital outcomes after bariatric surgery in patients with heart failure	9
Performance of the ESC 0/2h-algorithm using high-sensitivity cardiac troponin I in the early diagnosis of myocardial infarction	9
Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy	9
Cardiovascular determinants of impaired placental function in women with cardiac dysfunction	9
Sarcopenia in cardiac surgery: Dual X-ray absorptiometry study from the McGill frailty registry	9
Rationale and design of a pragmatic trial aimed at improving treatment of hyperlipidemia in outpatients with very high risk atherosclerotic cardiovascular disease: A pragmatic trial of messaging to pr	9
Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional D	9
Expansion of transcatheter aortic valve replacement in the United States	9
Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients	9
Dual antiplatelet therapy duration after percutaneous coronary intervention using drug eluting stents in high bleeding risk patients: A systematic review and meta-analysis	9
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	9
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	9
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and red	8
PROVIDE-HF primary results: Patient-Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (sacubitril/valsartan) in heart failure	8
Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial	8
Preexisting frailty and outcomes in older patients with acute myocardial infarction	8
Sacubitril/valsartan vs ACEi/ARB at hospital discharge and 5-year survival in older patients with heart failure with reduced ejection fraction: A decision analysis approach	8
Temporal trends in risk profiles among patients hospitalized for heart failure	8
Comparison of severe maternal morbidity in pregnancy by modified World Health Organization Classification of maternal cardiovascular risk	8
Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection	8
Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study	8
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	8
Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism—the Find-AF 2 study—rationale and design	8
Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair	8
Atrial fibrillation burden and cognitive decline in elderly patients undergoing continuous monitoring	8
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics	8
Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis	8
Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program	8
Potential impact of the steroid hormone, vitamin D, on the vasculature	8
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	8
Interobserver agreement of the anatomic and physiological classification system for adult congenital heart disease	8
Risk markers of incident atrial fibrillation in patients with coronary heart disease	8
Patient evaluation of a virtual visit program for adults with congenital heart disease	8
Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design	8
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care	8
Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of	7
βeta blocker interruption after uncomplicated myocardial infarction: rationale and design of the randomized ABYSS trial	7
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials	7
Select drug-drug interactions with colchicine and cardiovascular medications: A review	7
Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial	7
A review of polypills for the prevention of atherosclerotic cardiovascular disease	7
Novel plasma biomarkers predicting biventricular involvement in arrhythmogenic right ventricular cardiomyopathy	7
Identifying Mechanisms Underlying the Association Between Cardiovascular Diseases and Periodontitis Using in Silico Analysis of Canonical Pathways	7
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction – findings from the LATITUDE–TIMI 60 trial	7
NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial	7
Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study	7
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	7
Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims data	7
Association between race/ethnicity and income on the likelihood of coronary revascularization among postmenopausal women with acute myocardial infarction: Women's health initiative study	7
Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials	7
Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study	7
Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eB	7
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey	7
Intestinal barrier dysfunction is associated with elevated right atrial pressure in patients with advanced decompensated heart failure	7
Effect of permanent right internal mammary artery occlusion on right coronary artery supply: A randomized placebo-controlled clinical trial	7
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial	7
Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography	7
Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease	7
Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementat	7
Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial	7
Cardiac rehabilitation availability and characteristics in Latin America and the Caribbean: A Global Comparison	7
The role of cardiac testing with the 0/1-hour high-sensitivity cardiac troponin algorithm evaluating for acute myocardial infarction	7
Levothyroxine dose and risk of atrial fibrillation: A nested case-control study	7
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomize	6
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	6